3D-PHAD

3D-PHAD ,欢迎访问官网了解更多产品信息和订购。
3D-PHAD

详情介绍

Synonym: 3D-PHAD; Monophosphoryl 3-Deacyl Lipid A

IUPAC/Chemical Name: ammonium (2R,3S,4R,5R,6R)-2-(hydroxymethyl)-5-((R)-3-(tetradecanoyloxy)tetradecanamido)-4-(((R)-3-(tetradecanoyloxy)tetradecanoyl)oxy)-6-(((2R,3S,4R,5R,6S)-3,4,6-trihydroxy-5-((R)-3-hydroxytetradecanamido)tetrahydro-2H-pyran-2-yl)methoxy)tetrahydro-2H-pyran-3-yl hydrogen phosphate

InChi Key: XERJCJBCCDONJL-WOBTUNBLSA-N

InChi Code: InChI=1S/C82H155N2O20P.H3N/c1-6-11-16-21-26-31-33-38-43-48-53-58-72(89)99-66(56-51-46-41-36-29-24-19-14-9-4)61-71(88)84-76-80(103-74(91)62-67(57-52-47-42-37-30-25-20-15-10-5)100-73(90)59-54-49-44-39-34-32-27-22-17-12-7-2)79(104-105(95,96)97)68(63-85)102-82(76)98-64-69-77(92)78(93)75(81(94)101-69)83-70(87)60-65(86)55-50-45-40-35-28-23-18-13-8-3;/h65-69,75-82,85-86,92-94H,6-64H2,1-5H3,(H,83,87)(H,84,88)(H2,95,96,97);1H3/t65-,66-,67-,68-,69-,75-,76-,77-,78-,79-,80-,81+,82-;/m1./s1

SMILES Code: O[C@H]([C@@H](CO[C@@H]([C@@H]1NC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)O[C@H](CO)[C@@H](OP([O-])(O)=O)[C@@H]1OC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)O[C@H](O)[C@@H]2NC(C[C@H](O)CCCCCCCCCCC)=O)[C@@H]2O.[NH4+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

3D-PHAD 

MedKoo 是超高质量的实验室药物供应商。它于2009年由获得博士学位的Qingqi Chen博士创立。北京大学合成化学专业,并在约翰内斯-开普勒大学林茨(与 Heinz Falk 博士)、内华达里诺大学(与 David Lightner 博士)和不列颠哥伦比亚大学(与 David Dolphin 博士)接受博士后培训。

3D(6-acyl) PHAD

3D(6-acyl) PHAD ,欢迎访问官网了解更多产品信息和订购。
3D(6-acyl) PHAD

详情介绍

Synonym: 3D(6-acyl) PHAD; Monophosphoryl Hexa-acyl Lipid A, 3-Deacyl

IUPAC/Chemical Name: ammonium (2R,3S,4R,5R,6R)-2-(hydroxymethyl)-5-((R)-3-(tetradecanoyloxy)tetradecanamido)-4-(((R)-3-(tetradecanoyloxy)tetradecanoyl)oxy)-6-(((2R,3S,4R,5R,6S)-3,4,6-trihydroxy-5-((R)-3-(tetradecanoyloxy)tetradecanamido)tetrahydro-2H-pyran-2-yl)methoxy)tetrahydro-2H-pyran-3-yl hydrogen phosphate

InChi Key: BKGJOWVNLQLVQX-ZLHZNJIMSA-N

InChi Code: InChI=1S/C96H181N2O21P.H3N/c1-7-13-19-25-31-37-40-46-52-58-64-70-85(102)113-78(67-61-55-49-43-34-28-22-16-10-4)73-83(100)97-89-92(107)91(106)82(116-95(89)108)77-112-96-90(98-84(101)74-79(68-62-56-50-44-35-29-23-17-11-5)114-86(103)71-65-59-53-47-41-38-32-26-20-14-8-2)94(93(81(76-99)117-96)119-120(109,110)111)118-88(105)75-80(69-63-57-51-45-36-30-24-18-12-6)115-87(104)72-66-60-54-48-42-39-33-27-21-15-9-3;/h78-82,89-96,99,106-108H,7-77H2,1-6H3,(H,97,100)(H,98,101)(H2,109,110,111);1H3/t78-,79-,80-,81-,82-,89-,90-,91-,92-,93-,94-,95+,96-;/m1./s1

SMILES Code: O[C@H]([C@@H](CO[C@@H]([C@@H]1NC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)O[C@H](CO)[C@@H](OP([O-])(O)=O)[C@@H]1OC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)O[C@H](O)[C@@H]2NC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)[C@@H]2O.[NH4+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

3D(6-acyl) PHAD

MedKoo 是超高质量的实验室药物供应商。它于2009年由获得博士学位的Qingqi Chen博士创立。北京大学合成化学专业,并在约翰内斯-开普勒大学林茨(与 Heinz Falk 博士)、内华达里诺大学(与 David Lightner 博士)和不列颠哥伦比亚大学(与 David Dolphin 博士)接受博士后培训。